[SYRS] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
14-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -10.71%
YoY- -90.68%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 386 3,762 2,833 2,954 -5,467 -
PBT -23,327 -3,708 -64,384 -40,143 -36,258 -23,789 -4,774 188.22%
Tax 0 291 10,883 -3,296 1,278 -8,865 -32,349 -
NP -23,327 -3,708 -64,384 -40,143 -36,258 -14,924 27,575 -
Tax Rate - - - - - - - -
Total Cost 23,327 3,708 64,770 43,905 39,091 17,878 -33,042 -
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 -16,679.79 -1,067.07 -1,279.84 -505.21 -504.39 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.59 -0.10 -2.18 -1.43 -1.30 -0.54 0.99 -
EPS Diluted -0.59 -0.10 -2.18 -1.43 -1.30 -0.54 0.99 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.